Atara Biotherapeutics, Inc.

ATRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Mar 4, 2024
144 Mar 4, 2024
144 Mar 4, 2024
144 Mar 4, 2024
144 Mar 4, 2024
8-K Feb 23, 2024 8-K
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G/A Feb 13, 2024 SCHEDULE 13G/A
SC 13G/A Feb 9, 2024
SC 13G/A Feb 6, 2024
SC 13G/A Jan 26, 2024
SC 13G/A Jan 22, 2024
4 Jan 9, 2024
4 Jan 9, 2024
4 Jan 9, 2024
4 Jan 9, 2024
4 Jan 9, 2024
424B5 Jan 9, 2024 424B5
SC 13G/A Jan 9, 2024 NONE
8-K Jan 9, 2024 8-K
8-K Jan 8, 2024 8-K
S-8 Jan 3, 2024 S-8
8-K Dec 20, 2023 8-K
SC 13G/A Dec 7, 2023 FILING ATARA BIOTHERAPEUTICS, INC.
← Newer Page 9 of 46 · 1130 filings Older →